Page last updated: 2024-10-20

pyrazinamide and Alveolar Bone Atrophy

pyrazinamide has been researched along with Alveolar Bone Atrophy in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, RS1
Farquharson, AA1
Nasseri, S1

Other Studies

1 other study available for pyrazinamide and Alveolar Bone Atrophy

ArticleYear
Bilateral bone loss of the maxilla.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2003, Volume: 96, Issue:1

    Topics: Adult; Alveolar Bone Loss; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; H

2003